Cargando…
Rational Design and Synthesis of AT1R Antagonists
Hypertension is one of the most common diseases nowadays and is still the major cause of premature death despite of the continuous discovery of novel therapeutics. The discovery of the Renin Angiotensin System (RAS) unveiled a path to develop efficient drugs to fruitfully combat hypertension. Severa...
Autores principales: | Georgiou, Nikitas, Gkalpinos, Vasileios K., Katsakos, Spyridon D., Vassiliou, Stamatia, Tzakos, Andreas G., Mavromoustakos, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156919/ https://www.ncbi.nlm.nih.gov/pubmed/34069122 http://dx.doi.org/10.3390/molecules26102927 |
Ejemplares similares
-
Rational Drug Design and Synthesis of Molecules Targeting the Angiotensin II Type 1 and Type 2 Receptors
por: Kellici, Tahsin F., et al.
Publicado: (2015) -
On the Rational Drug Design for Hypertension through NMR Spectroscopy
por: Chontzopoulou, Eleni, et al.
Publicado: (2020) -
Conformational Properties and Putative Bioactive Targets for Novel Thiosemicarbazone Derivatives
por: Georgiou, Nikitas, et al.
Publicado: (2022) -
Conformational Properties of New Thiosemicarbazone and Thiocarbohydrazone Derivatives and Their Possible Targets
por: Georgiou, Nikitas, et al.
Publicado: (2022) -
Interplay of cholesterol, membrane bilayers and the AT1R: A cholesterol consensus motif on AT1R is revealed
por: Kiriakidi, Sofia, et al.
Publicado: (2020)